Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Blagec

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Nature Communications|November 10, 2022
Mapping global dynamics of benchmark creation and saturation in artificial intelligenceSimon Ott, Adriano Barbosa-Silva, Kathrin Blagec, et al.
Studies in Health Technology and Informatics|August 28, 2014
Towards a global IT system for personalized medicine: the Medicine Safety Code initiativeMatthias Samwald, José Antonio Minarro-Giménez, Kathrin Blagec, et al.
Plos One|May 3, 2014
An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-careJose Antonio Miñarro-Giménez, Kathrin Blagec, Richard D Boyce, et al.
Plos One|October 21, 2016
Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are AvailableMatthias Samwald, Hong Xu, Kathrin Blagec, et al.
Journal of the American Medical Informatics Association : JAMIA|February 15, 2018
Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) projectKathrin Blagec, Rudolf Koopmann, Mandy Crommentuijn-van Rhenen, et al.
Plos One|June 8, 2022
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countriesKathrin Blagec, Jesse J Swen, Rudolf Koopmann, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE StudyHenk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson, et al.
Eclinicalmedicine|January 8, 2026
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE studyVasileios Fragoulakis, Jesse J Swen, Margarita-Ioanna Koufaki, et al.
Lancet (London, England)|February 4, 2023
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J Swen, Cathelijne H van der Wouden, Lisanne En Manson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nature Communications|November 10, 2022
Mapping global dynamics of benchmark creation and saturation in artificial intelligenceSimon Ott, Adriano Barbosa-Silva, Kathrin Blagec, et al.
Studies in Health Technology and Informatics|August 28, 2014
Towards a global IT system for personalized medicine: the Medicine Safety Code initiativeMatthias Samwald, José Antonio Minarro-Giménez, Kathrin Blagec, et al.
Plos One|May 3, 2014
An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-careJose Antonio Miñarro-Giménez, Kathrin Blagec, Richard D Boyce, et al.
Plos One|October 21, 2016
Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are AvailableMatthias Samwald, Hong Xu, Kathrin Blagec, et al.
Journal of the American Medical Informatics Association : JAMIA|February 15, 2018
Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) projectKathrin Blagec, Rudolf Koopmann, Mandy Crommentuijn-van Rhenen, et al.
Plos One|June 8, 2022
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countriesKathrin Blagec, Jesse J Swen, Rudolf Koopmann, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE StudyHenk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson, et al.
Eclinicalmedicine|January 8, 2026
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE studyVasileios Fragoulakis, Jesse J Swen, Margarita-Ioanna Koufaki, et al.
Lancet (London, England)|February 4, 2023
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J Swen, Cathelijne H van der Wouden, Lisanne En Manson, et al.
Pageof 2